Your browser doesn't support javascript.
loading
Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose.
Regula, Prudhvi; Rosenstreich, David; Jerschow, Elina; Ramesh, Manish; Ferastraoaru, Denisa; Oh, Jessica; Aivazi, Daniella S; Aivazi, Jonathan M; Hudes, Golda.
Afiliação
  • Regula P; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
  • Rosenstreich D; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
  • Jerschow E; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
  • Ramesh M; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
  • Ferastraoaru D; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
  • Oh J; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
  • Aivazi DS; CUNY School of Medicine, the Sophie Davis School of Biomedical Education Program, New York, NY.
  • Aivazi JM; the New York Institute of Technology College of Osteopathic Medicine, Glen Head, NY.
  • Hudes G; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
J Allergy Clin Immunol Glob ; 1(3): 175-177, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36164368
ABSTRACT
Current guidelines do not recommend subsequent mRNA COVID-19 vaccination in patients who experience immediate allergic reactions to the first dose. Our findings indicate that graded dosing of this vaccine is safe, efficacious, and useful for treating these individuals with allergy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Glob Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Glob Ano de publicação: 2022 Tipo de documento: Article